Anaplastic Astrocytoma
122
12
20
62
Key Insights
Highlights
Success Rate
73% trial completion
Published Results
29 trials with published results (24%)
Research Maturity
62 completed trials (51% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
18.9%
23 terminated out of 122 trials
72.9%
-13.6% vs benchmark
7%
9 trials in Phase 3/4
47%
29 of 62 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 62 completed trials
Clinical Trials (122)
INCB7839 in Treating Children With Recurrent/Progressive High-Grade Gliomas
A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma
Targeted Pediatric High-Grade Glioma Therapy
Pediatric Long-Term Follow-up and Rollover Study
Adaptive Radiotherapy and MRIs Based on Patients With Newly Diagnosed High-Grade Glioma
A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas
Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma
Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations
Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
Loupe-Based Intraoperative Fluorescence Imaging
A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma
Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab Plus Carboplatin For Treatment Of Relapsed/Refractory GBM And Anaplastic Astrocytoma
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
DB107-Retroviral Replicating Vector (RRV) Combined With DB107-Flucytosine (FC) in Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma
Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma
Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children, Adolescents, and Young Adults With Brain Tumors
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM